Tag: Neurogenic bladder

Bethanechol, first synthesized in 1935, is a well-established cholinergic agonist primarily utilized for specific bladder disorders. But what conditions does bethanechol treat? It is most often prescribed to address non-obstructive urinary retention by helping the bladder muscle contract more effectively.

According to research published by the National Institutes of Health, anticholinergic drugs like oxybutynin have long been a mainstay for treating neurogenic detrusor overactivity. However, the specific **drug of choice for neurogenic bladder** is highly individualized, depending on the patient's symptoms, the underlying neurological condition, and their response to different treatments.

Over half of all patients undergoing adrenalectomy for pheochromocytoma were treated with phenoxybenzamine in 2008, highlighting its importance in managing this condition. **What is Phenoxybenzamine used for?** It is a powerful alpha-adrenergic blocker with a primary application in treating high blood pressure caused by specific adrenal gland tumors.